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Summary 
The preadipose cell line, PA6, can support long-term hemopoiesis. Frequency of the hemopoietic 
stem cells capable of sustaining hemopoiesis in cocultures of bone marrow cells and PA6 cells 
for 6 wk was 1/5.3  x  10  4 bone marrow cells. In the group of dishes into which bone marrow 
cells had been inoculated at 2.5  x  10  4 cells/dish,  3 of 19 dishes  (16%) contained stem cells 
capable of reconstituting erythropoiesis of WBB6FI-kV/W  ~ mice, indicating that PA6 cells can 
support the proliferation of primitive hemopoietic stem cells. When the cocultures were treated 
with an antagonistic anti-c-kit monoclonal antibody, ACK2,  only a small number of day 12 
spleen colony-forming units survived;  and hemopoiesis was severely reduced. However, when 
the cocultures were continued with antibody-free medium, hemopoiesis dramatically recovered. 
To examine the proliferative properties of the ACK2-resistant stem cells, we developed a colony 
assay system by modifying our coculture system.  Sequential observations of the development 
of individual colonies and their disappearance demonstrated that the stem cells having higher 
proliferative capacity preferentially survive the ACK2 treatment. Furthermore, cells of subclones 
of the PA6 clone that were incapable of supporting long-term hemopoiesis expressed mRNA 
for the c-kit ligand. These results suggest that a mechanism(s) other than that involving c-kit 
receptor and its ligand plays an important role in the survival and proliferation of primitive 
hemopoietic stem cells. 
T 
he hemopoietic stem cell is characterized  by its exten- 
sive self-maintenance capacity and differentiation potential 
(1). It is well established that a single stem cell can give rise 
to cells of all lymphohemopoietic  lineages (2-4). Such stem 
cells have been operationally defined and assayed by their ca- 
pacity for long-term repopulation of lymphohemopoietic  cells 
after injection of them into either lethally irradiated or ge- 
netically anemic WBB6F1-W/W ~ mice (5-8).  These stem 
cells are physically separable from the majority of the cells 
that form macroscopic colonies in the spleens of lethally ir- 
radiated mice (spleen colony-forming units [CFU-S] 1) (9-11). 
1  Abbreviations used in this ~per: CFU-S,  spleen colony-forming units; 
DEX, dexamethasone;  HS, horse serum;  SI, steel;  W, white spotting. 
However, biological properties of the primitive hemopoietic 
stem cells are poorly understood. One of the difficulties in 
studying this problem is the absence of an in vitro assay system 
of the stem cells. In the long-term bone marrow culture 
system, hemopoiesis is sustained for several months in close 
association with an adherent stromal cell layer (12). Although 
primitive hemopoietic stem cells are known to be present in 
this culture system for at least 4 wk (13-15),  neither have 
they been  quantitatively assessed nor has  the mechanism 
responsible for their proliferation and differentiation been 
clarified. 
On the other hand, mice bearing mutations at the domi- 
nant white spotting (/4/) locus have long been believed to 
have a defect intrinsic to hemopoietic stem cells (16). The 
W locus has been shown to be allelic with the c-kit proto- 
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receptor family (17, 18). Furthermore, the ligand for this 
receptor (c-kit ligand) has been identified as the product of 
the steel (SI)  locus (19-21). 
Recently, a mAb, ACK2, recognizing an extracellular do- 
main of the c-kit receptor molecule has been developed (22, 
23). This antibody has been strongly suggested to antagonisti- 
cally block the function of the c-kit receptor and to be cytostatic 
rather than cytotoxic for the cells expressing its antigen (22, 
23). Most hemopoietic progenitor cells, including the stem 
cells capable of reconstituting in vivo lymphohemopoiesis, 
have been shown to express the c-kit molecule (23-25). Most 
of the donogenically assayable  progenitor cells in bone marrow 
are depleted by the injection of ACK2 (23). Also, colony for- 
mation of CFU-S is inhibited by the injection of the anti- 
body (24). These findings demonstrate that the c-kit mole- 
cule and its ligand play an essential role in the constitutive 
hemopoiesis in vivo. However, a small but significant frac- 
tion of day 13 CFU-S is resistant to the antagonistic anti- 
body (23),  and sensitivity of day 12  CFU-S  to ACK2 is 
significantly lower than that of day 8 CFU-S (24).  These 
findings raise the question as to whether the c-kit receptor 
is functionally  requisite for the proliferation of the hemopoietic 
stem cells at an early stage. 
In  this  study,  we  found that  our  preadipose  cell  line, 
MC3T3-G2/PA6 (PA6) (26-28), can support the prolifera- 
tion of  hemopoietic stem cells capable of  reconstituting whole 
erythropoiesis  of  WBB6F1-W/W v  mice  for  24  wk.  By 
modifying the coculture system of bone marrow cells and 
PA6 cells, we developed an in vitro colony assay system for 
the detection of hemopoietic stem cells having varying prolifer- 
ative capacities. Then, taking advantage of the ACK2 mAb 
and subclones of PA6 clone that were incapable of supporting 
long-term hemopoiesis, we obtained data strongly suggesting 
the presence of a mechanism(s) other than that involving the 
c-kit molecule and its ligand in the survival and proliferation 
of primitive hemopoietic stem cells. 
Materials and Methods 
Mice.  C57BL/6CrSIc,  WBB6F1-W/I4~, and  WB/Re  mice 
were  purchased from  Shizuoka Laboratory  Animal  Center 
(Hamamatsu, Japan). These mice were used at 6-10 wk of age. 
Cell Lines.  All cultures were incubated at 37~  in a fully hu- 
midified atmosphere of 5% CO2 in air. The donal preadipose cell 
line PA6 (26-28) and the bone marrow-derived stromal cell line 
ST2 (29, 30) have been described previously. Subdones 2, 12, and 
14 were isolated from the parental PA6 done and selected on the 
basis of their inability to support long-term bemopoiesis. 
Anti-c-kit  mAb  and  Recombinant  Mouse  c-kit  Ligand  (tree-kit 
Ligand).  Purified  ACK2 mAb recognizing an extracelluhr domain 
of the mouse c-kit molecule was prepared as described previously 
(22, 23). For the preparation  of  rmc-kit  ligand, eDNA corresponding 
to the extracellular  domain of  mouse c-k/t  ligand (amino adds 1-185) 
was amplified  by the reverse transcription (RT)-PCR method and 
cloned into pYZ10 yeast  expression vector. The vector was trans- 
fected into yeast to result in the secretion of rmc-kit llgand into 
culture medium. The culture medium was concentrated by ultra- 
filtration and subjected to partial purification steps by Mono Q 
anion-exchange (Pharmada LKB  Biotechnology,  Uppsala, Sweden) 
and Phenyl-superose  (Pharmacia  LKB  Biotechnology)  column chro- 
matography. Activity of  rmc-kit ligand was detected by the inhibi- 
tion assay of ACK2 binding to Ib3-dependent mast cells derived 
from normal mice. Active  fractions  were pooled, concentrated, and 
dialyzed against PBS-. Concentration of tree-kit ligand was esti- 
mated by SDS-PAGE, and working dilution of this preparation was 
determined by the colony assay of mouse bone marrow ceils. 
Coculture of Bone Marrow Cells with PA6 Cells.  Confluent cell 
layers of parental PA6 clone, one of its subclones, or a 1:1 mixture 
of PA6 clone and one of the subclones were established as reported 
previously (28) in 35-ram dishes (Sumitomo Bakelite,  Tokyo,  Japan) 
coated with type I collagen (Nitta Gelatin, Osaka, Japan). Bone 
marrow cells from femurs of female C57BL/6 mice were inocu- 
lated onto the preadipocyte  layers at 3  x  10  s cells/dish and cocul- 
tured with 1.5 ml of c~-MEM (Irvine Scientific, Santa Ana, CA) 
supplemented with 20% horse serum (HS; HyClone  Laboratories, 
Logan, UT) and 10 -s M dexamethasone (DEX). Medium was 
changed twice a week. ACK2 antibody was added to the cocul- 
tures at the concentration of 0.1, 1, or 10 #g/ml. After 4 or 14 d 
of the antibody treatment, cocultures  were washed three times with 
medium and then continued with antibody-free medium. For the 
pretreatment of bone marrow cells with the ACK2, bone marrow 
cells were suspended at 2  x  10  s cells/ml in the  medium con- 
taining 10 #g/ml ACK2 and incubated at 37~  for 1 h. rmc-kit 
ligand was added at the concentration of 50 ng/ml. At every  twice- 
a-week medium change, nonadherent hemopoietic cells were har- 
vested by gentle pipetting  and rinsing once with medium and 
pooled. Number of the cells was determined with a hemocytom- 
eter. CFU-S assay was performed by counting of spleen colonies 
at 12 d after injection as described previously (27, 28). 
In Vitro Limiting Dilution Assay and In Vivo Reconstitution Assay 
of Hemopoietic Stem Cells.  Bone  marrow cells were inoculated  onto 
the cell layers of parental PA6 clone at varying cell dilutions (6.25 
x  103 to 1 x  10  s cells/35-mm dish) and cocultured as described 
above. On days  28, 35, and 42 ofcoculture, nonadherent cells were 
harvested and counted as described above. Dishes containing >5 
x  105 nonadherent cells were  judged as hemopoiesis  positive. Each 
cell dilution consisted  of 15-20 dishes. Frequency  of  the hemopoietic 
stem cells capable of sustaining hemopoiesis  within the cocultures 
in the bone marrow cell population was calculated according to 
the method described by Porter and Berry (31), Brevik (32), and 
Boggs et al. (5). 
On day 42, from the hemopoiesis-positive  dishes in the group 
in which bone marrow cells had been inoculated at 2.5  x  104 
cells/dish, hemopoietic cells associated  with the adherent cell layers 
were harvested  by treatment with 0.1% collagenase  (Nitta Gelatin) 
and removal of adherent cells by 1-h adherence to a plastic surface. 
The hemopoietic cells from individual dishes were intravenously 
injected into each WBB6F1-W/W ~ mouse. At 8, 12, 16, 20, and 
24 wk after the injection, peripheral blood of the mice was ob- 
tained by retroorbital puncture under anesthesia. Electrophoretic 
pattern of hemoglobin was determined after modification  with cys- 
tamine according to the method described by Whitney (33). He- 
moglobin of donor C57BL/6  mice carrying the "single" allele 
(Hbb'/Hbb') can be distinguished from that of recipient WBB6F1- 
W/W ~ mice carrying heterozygous combination of "diffuse" and 
"single" alleles (Hbba/Hbb% 
In Vitro Colony Assay of Hemopoietic Stem Cells.  Bone marrow 
cells were inoculated onto the cell layers of parental PA6 clone at 
5  x  104 or 2  x  10  s cells/60-mm dish (Sumitomo Bakelite) and 
cocultured in the absence or presence of 10/~g/ml ACK2 as de- 
scribed above. On day 2 or 4 of  coculture, after having been washed 
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2 ml of medium consisting of ot-MEM, 0.08%  type I collagen, 
20% HS, and 10 -8 M DEX. After the collagen had been allowed 
to gel at room temperature for 20 min, the cocultures were re- 
sumed. The next day, 3 ml of medium was added onto the gal. 
Then the medium was changed twice a week. Twice a week, colo- 
nies having a diameter of  2 mm or more and containing immature 
hemopoietic cells and/or both neutrophils and macrophages were 
counted as macroscopic  colonies  by examination  on an inverted mi- 
croscope at x40. For the sequential  observations  of  individual  colo- 
nies, location of newly emerging colonies within the dishes was 
recorded twice a week, and then presence of the colonies was in- 
spected. 
Detection of Transcript  oft-kit Ligand Gene after RT-PCR  Ampli- 
fication.  Total  RNA was prepared from 107 cells of parental PA6 
done, each of its subclones, or ST2 cell line by the guanidinium/ 
CsC1 method. The sequence of the synthetic oligonucleotide was: 
rat c-kit ligand, 5' primer; 5'-ATGAAGAAGACACAAACTTGG- 
ATT-Y, 3' primer;  5'-AATATYIGAAAACTTGTCCAGAAG-3; 
mouse ~-actin, 5' primer; 5'-TCGTGCGTGACATCAAAGAG-3; 
3' primer; 5'-TCd3ACAGTGAGGCCAGGATG-3'. These primers 
were synthesized with a PCR-Mate DNA synthesizer (391; Ap- 
plied Biosystems,  Inc., Foster City, CA). The isolated total RNA 
was reverse transcribed in a total volume of 20 pl in a buffer con- 
taining 50 mM Tris-HC1 (pH 8.3), 75 mM KC1, 3 mM MgClz, 
10 mM dithiothreitol,  10 mM dNTP mixture, 100 pmol random 
hexamer oligonucleotides  (Takara  Shuzo, Kyoto,  Japan), and 200 U 
Moloney murine leukemia  virus reverse transcriptase (Bethesda  Re- 
search Laboratories, Gaithersburg, MD).  dsDNA was then syn- 
thesized from the ssDNA with 1 U of Thermus  aquat/cus  (Taq) poly- 
merase (Takara  Shuzo), and the two pairs of  oligonudeotide primers 
by repeating 25-30 cycles of the PCR on a PCR Thermocycler 
(1000; Perkin Elmer Cetus, Norwalk,  CT).  Each cycle induded 
denaturation at 94~  for 1 rain, reannealing of the primer and 
fragmentation at 55~  for 2 rain, and polymerization of 75~  for 
2 min. A fraction of each sample of the amplified DNA was sub- 
jected to 5%  PAGE. DNA bands were stained with ethidium 
bromide. 
Results 
Abilit  7 of  PA6 Cells to Support the Proliferation  of  Hemopoietic 
Stem Cells Capable of  Reconstituting In Vivo Erythropoiesis.  Al- 
though the number of day 12 CFU-S increases ~12-fold after 
7 d ofcoculture with PA6 cells (28), and hemopoiesis within 
the cocultures continued for at least 15 wk (data not shown), 
it had not been assessed whether the preadipocytes can sup- 
port the proliferation of the hemopoietic stern cells capable 
of reconstituting in vivo hemopoiesis. 
To examine the growth of such stem cells within the cocul- 
tures, we first enumerated by limiting dilution analysis the 
frequency of the stem cells capable of sustaining hemopoiesis 
for up to 6 wk. Varying numbers of  bone marrow ceils were 
cocultured with PA6 cells. On days 28, 35, and 42 of cocul- 
ture, nonadherent cells were harvested and counted. Dishes 
containing >5  x  10  s nonadherent hemopoietic cells were 
judged as hemopoiesis positive. Most of the negative dishes 
contained much fewer nonadherent cells  than the number 
needed to meet our criterion, and their frequency increased 
as the culture period was prolonged, reflecting the decrease 
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Figure  1.  Limiting dilution 
analysis  of  the frequency  of  hemo- 
poietic stem ceils capable of sus- 
taining hemopoiesis within the 
cocultums  with  PA6 ~  Varying 
numbers of bone marrow ceils 
were inoculated  onto PA6 cell 
hyers  established  in 35-ram dishes 
and cocultured for 28 (11), 35 
(A), and 42 (O) d. Dishes con- 
raining  5  x  10  s nonadherent 
ceils or  more were judged as 
hemopoiesis  positive.  Each  ceil  di- 
lution consisted  of 15-20 dishes. 
in the number of the stem cells sustaining their proliferative 
capacity (Fig.  1). 
The proportion of the negative dishes was plotted against 
the inoculated number of bone marrow cells. From the data 
obtained on day 28, 35, and 42 of coculture, straight regres- 
sion lines were obtained in a semilogarithmic plot that inter- 
cepted the ordinate at 1.04, 1.08, and 0.99, respectively (Fig. 
1). The frequency of the stem cells that sustained hemopoi- 
esis within the cocultures for 28, 35, and 42 d was estimated 
to be  1/3.2  x  104  ,  1/4.5  x  104, and  1/5.3  x  104 bone 
marrow cells, respectively. 
In the group of dishes into which bone marrow cells had 
been inoculated at 2.5  x  104 cells/dish,  7 of 19 dishes (37%) 
were positive for hemopoiesis on day 42 of coculture. We 
harvested hemopoietic cells associated with adherent cell layers 
of these hemopoiesis-positive  dishes individually  and injected 
them into each of seven WBB6F1-W/W v mice. Fig. 2 shows 
electrophoretic patterns of hemoglobin from these recipient 
mice at 24 wk after the injection. Hemoglobin from two 
of these mice (lanes 4 and 5) showed a pure Hbb'/Hbb  s pat- 
tern, indicating that whole erythropoiesis of these mice had 
been reconstituted by the hemopoietic stem cells derived from 
donor C57BL/6 mice.  In these mice, the pure Hbbs/Hbb  ' 
pattern had been observed already at 8 wk after the injec- 
tion. In one mouse (lane 9), erythropoiesis was partially recon- 
Figure 2.  Electrophoretic  patterns of hemoglobin from WBB6F1- 
W/W  ~  mice  injected  with hemopoietic  cells harvested  from the cocultures 
of bone marrow ceils and PA6 cells. In the experiment shown  in Fig. 1, 
in the group of day 42 cocultures  in which  bone marrow cells had been 
inoculated  at 2.5  x  104 ceils/dish, 7 of 19 dishes were hemopoiesis  posi- 
tive. Hemopoietic  cells  were  harvested  from  each  hemopoiesis-positive  dish 
and injected  into each of seven WBB6F1-W/W, mice. Peripheral  blood 
was obtained from a C57BL/6 mouse (hne I), a WB/Re mouse (lane 
2),  an uninjected WBB6FvW/W~ mouse (lane 3), or seven recipient 
WBB6FrW/W, mice (lanes 4-10) at 24 wk after the injection. 
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hemoglobin, as well as that of the recipient type, had been 
dearly noticed from 16 wk after the injection. These results 
demonstrate that PA6 ceils can support the proliferation of 
hemopoietic stem cells having extensive proliferative capacity. 
Effect of an Anti-c-kit mAb on the Hemopoiesis Supported by 
PA6 Cells.  The mAb ACK2, recognizing an extracellular 
domain of the c-kit receptor molecule, has been strongly sug- 
gested to act as an antagonist and to be cytostatic rather than 
cytotoxic for the cells expressing the antigen (22,  23).  To 
ducidate the functional role of the c-kit  molecule in the 
proliferation of hemopoietic stem ceUs in our coculture system, 
we first examined the effect of the antibody on the produc- 
tion of nonadherent hemopoietic cells. Purified ACK2 was 
added to the cocultures at varying concentrations at the onset 
of the cocultures, and then the cocultures were continued 
with antibody-free medium from day 4. 
As shown in Fig. 3, ACK2 dose-dependently reduced the 
production of nonadherent hemopoietic cells. In the cocul- 
tures treated with 10/~g/ml ACK2, nonadherent cell produc- 
tion rapidly declined to the level as low as 1-2% of that in 
the untreated cocultures during the second week of cocul- 
ture. During the fourth and fifth weeks, however, hemopoi- 
esis within the ACK2-treated cocultures dramatically became 
active, and production of nonadherent cells reached the level 
of that in the untreated cocultures. The number of day 12 
CFU-S decreased to ,,o6%  of the inoculated number after 
4 d of coculture in the presence of 10/~g/ml ACK2, whereas 
the CFU-S number in the untreated cocultures increased about 
threefold over the same period (Fig.  4). 
To exclude the possibility that the recovery of hemopoi- 
esis was due to insufficiency  of the ACK2 treatment, we repeat- 
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Figure 4.  Effect of ACK2 on 
the number of CFU-S within the 
cocultures  of bone marrow cells 
and PA6 cells. Bone marrow cells 
were  inoculated  at  3  x  10  s 
cells/35-mm dish onto PA6 cell 
layers and cocultured in the ab- 
sence or  presence  of 10  /~g/ml 
ACK2 antibody  for 4 d. Hemo- 
poietic cells harvested  from the 
c~fltures or freshly isohted from 
bone marrow were injected into 
lethally irradiated  mice. At 12 d 
after the injection, spleen colonies 
were counted.  Each column rep- 
resents the mean _+ SD of counts 
from eight spleens. 
edly added ACK2 to the cocultures on days 0, 4, 7, and 11 
of coculture, and then the cocultures were continued with 
antibody-free medium from day 14. Even this prolonged ACK2 
treatment could not abrogate the recovery of hemopoiesis, 
although the reduction of hemopoiesis was more severe and 
recovery delayed (Fig.  5). Next, we examined the effect of 
pretreatment of bone marrow cells with the antibody. Bone 
marrow cells were incubated with ACK2 at 37~  for 1 h 
before the ACK2 treatment of the cocultures for the initial 
4 d. The stem cells responsible for the recovery of hemopoi- 
esis still could survive this intense ACK2 treatment (Table 
1). These results strongly suggest that the c-kit molecule is 
not functionally requisite for the survival and proliferation 
of a certain population of hemopoietic stem cells. 
Colony Formation of  Hemopoietic Stem Cells witlzin the Cocul- 
tures of Bone Marrow Cells and PA6 Cells and Sensitivity of the 
Clo,ogenic Cells to ACK2 Treatment.  To elucidate the prolifer- 
ative properties of the hemopoietic stem cells surviving the 
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Figure 3.  Effect of anti-c-kit  mAb on the hemopoiesis  supported  by 
PA6 calls. Bone marrow ceils were inoculated  at 3  x  10  s cells/35-mm 
dish onto PA6 cell layers and cocultured for 35 d. Purified ACK2 mAb 
was added  to the cocultures  at the concentration of 0 (e), 0.1 (A),  1 
(V), or 10 (I)/zg/ml at the onset of the cocultures. On day 4, the cocul- 
tares were washed three times with medium. Then the cocultures  were 
continued with antibody-free medium by changing of the medium twice 
a week. At every medium change, nonadherent  cells were harvested from 
at least four dishes by gentle pipetting and rinsing once with medium, 
pooled, and counted. 
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Figure 5.  Effect of prolonged ACK2 treatment on the hemopoiesis sup- 
ported by PA6 cells. Bone marrow  cells were inoculated  at  3  x  10  s 
cells/35-mm dish onto PA6 cell layers and cocultured in the absence (e) 
or presence (&) of 10/~g/ml ACK2 for 14 d with medium change twice 
a week. Then, after  having been washed  with medium, the cocultures 
were continued with antibody-free  medium. At every medium change, 
nonadherent  cells were counted as described in the legend to Fig. 3. 
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ACK2  on  the Survival of Hemopoietic Stem  Cells 
ACK2  treatment  No.  of nonadherent  cells/dish* 
Preincubation*  CocultureS  On  day  14  On  day 28 
-  -  3.5  x  106  2.7  x  106 
-  +  5.0  x  104  2.1  x  10  ~ 
+  +  5.0  x  104  1.2  x  106 
" Nonadherent  cells were harvested and counted as described in the legend 
to Fig.  3. 
Bone marrow cells were suspended at 2  x  10  s cell/ml in the medium 
and incubated  at 37~  for 1 h in the absence or presence of 10/~g/ml 
ACK2. 
S Bone marrow cells were inoculated  at 3  x  105 cells/35-mm dish onto 
PA6 cell layers and cocultured in the absence or presence of 10/~g/ml 
ACK2 for the initial 4 d. Then, after having been washed with medium, 
the cocultures  were continued with antibody-free  medium, which was 
changed twice a week. 
ACK2 treatment and to compare them with those of ACK2 
sensitive stem cells, we developed a colony assay system of 
hemopoietic stem cells by modifying our coculture system. 
Since cell-to-cell contact with PA6 cells is a requisite for the 
proliferation  of CFU-S (27),  and most of the CFU-S and 
progenitor cells  of  neutrophils and macrophages are distributed 
within the PA6 cell layers (28), we first cocultured bone 
marrow cells and PA6 cells with liquid medium for 2-4 d, 
and then the adherent cell layers were covered with a col- 
lagen gel. These semisolidified  cocultures could be continued 
for up to 6-7 wk by changing of the medium that was added 
onto the gel. 
Colonies  having a diameter of 2 mm or more and con- 
taining immature hemopoietic cells and/or both neutrophils 
and macrophages were counted as macroscopic colonies (Fig. 
6).  At their early stage of development,  the colonies con- 
tained only immature hemopoietic cells, and later these cells 
differentiated into neutrophils  or macrophages. Some of the 
neutrophils  moved up to the liquid phase. Colonies tended 
to become larger with increasing time in coculture, and their 
diameter reached up to 6 mm (Fig. 6, right). When the colo- 
nies came to the end of their existence, the neutrophils in 
the colonies died simultaneously. We judged such colonies 
as having disappeared, although macrophages in these colo- 
nies survived for a long time after the loss of neutrophils and 
gradually dispersed. Length of the period of liquid culture 
within the range of 2 and 4 d did not affect either number 
or size of the colonies (data not shown). 
Fig. 7 shows the time course of change in the number of 
macroscopic colonies in the cocultures in which bone marrow 
cells were inoculated  at 2  x  10  s cells/60-mm dish.  In the 
untreated cocultures, many macroscopic colonies were already 
detected on day 7. At this inocuhm size, however, counting 
of the colonies was hampered by the presence of many small 
colonies. By day 11, however, most of the small colonies had 
disappeared, and '~,70 discrete macroscopic colonies were de- 
tected per dish. The colony number decreased to about half 
at every twice-a-week counting until day 32.  Then as few 
as 1.5-2  colonies were observed per dish until day 42. 
When the cocultures were treated with 10/zg/ml ACK2 
during the 4-d period of liquid culture,  1.6  _+  1.3 macro- 
scopic colonies first developed per dish on day 11. Then the 
colony number never exceeded six colonies/dish throughout 
our observation period up to day 42 (Fig. 7). Nevertheless, 
at later than day 28, the colony number in the ACK2-treated 
cocultures was comparable to that in the untreated cocul- 
tures.  Colonies  developed within the ACK2-treated  cocul- 
tures  tended to become larger than those in the untreated 
cocultures, and the diameter of some colonies reached up to 
10 mm at later than day 25. These results demonstrate that 
hemopoietic stem cells forming colonies earlier within the 
cocultures  are selectively killed by the ACK2  treatment. 
Figure 6.  Macroscopic  colonies 
formed in the semisolidified cocul- 
tures.  Bone marrow cells were in- 
oculated  at  2  x  10  s cells/60-mm 
dish onto PA6 cell layers and cocul- 
tured in liquid medium. On day 2, 
adherent  cell  layers were  covered 
with a collagen gel. Then the cocul- 
tures  were continued by changing 
of the medium added onto the gel 
twice a  week  for  14  (/eft) or 28 
(right) d. Then the cocultures were 
dehydrated  by covering  of the gel 
with a lens paper and filter papers, 
fixed  with  10%  formalin,  and 
stained  with hematoxylin. 
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Figure 7.  Time course of  the change in the number of macroscopic  colo- 
nies in the untreated and ACK2-treated  bone marrow/PA6 cocukures. Bone 
marrow cells were inoculated at 2 x  105 cdls/60-mm dish onto PA6 cell 
layers and cocuhured in the absence (O) or presence (A) of 10/zg/ml 
ACK2 with liquid medium for 4 d. Then, after having been washed with 
medium, the adherent cell layers were covered with a collagen gel. The 
cocuttures were continued by changing of the medium, added onto the 
gel, twice a week. Colonies having a diameter of 2 mm or more and con- 
taining immature hemopoietic cells and/or both nentrophils and macro- 
phages were counted as macroscopic colonies. Each point represents the 
mean  •  SD of counts from at least four dishes. 
Table  2.  Development  of Macroscopic Colonies and Their 
Disappearance within the Cocultures of Bone Marrow Cells 
and PA6 Cells 
Period of persistence 
of macroscopic colonies  No.  of colonies" 
Day 7  72 
Day 7-11  12 
Day 7-14  4 
Day 7-18  1 
Day 11  18 
Day 11-14  11 
Day 11-18  3 
Day 11-25  1 
Day 14  10 
Day 14-18  2 
Day 14-25  1 
Day 18  4 
Day 21-25  1 
Day 32-42  1 
8 
8 
8 
o  o 
o 
8 
V -o 
28  35  42 
Days ifl cocut~ure 
Figure 8.  Development of individual macroscopic colonies and their 
persistence in the ACK2-treated cocultures. Conditions of cocultures of 
bone marrow cells and PA6 cells and ACK2 treatment were similar to 
those described in the legend to Fig. 7. Twice a week, location of newly 
emerging colonies within three dishes was recorded, and their persistence 
was inspected. 
Next,  to disclose the proliferative properties of the stem 
cells forming colonies in our coculture system more precisely, 
we sequentially observed the development of individual mac- 
roscopic colonies and their disappearance by recording the 
location of newly emerging colonies twice a week and in- 
specting their persistence. To facilitate the identification of 
the colonies formed in the untreated cocultures, we reduced 
inoculum  size  of  the  bone  marrow  cells  to  5  x  104 
cells/dish. Adherent cell layers were covered with a collagen 
gel on day 2  of coculture. As shown in Table 2,  a total of 
141  macroscopic colonies were formed in two  such dishes 
during a 6-wk observation period. 89 colonies (63%) reached 
macroscopic size on day 7. 104 colonies (74%) were detected 
at only one observation time. Only 11 colonies (8%) were 
detected at more than three observation times, i.e., for >8 
'~10" 
lo  a 
Days In cocutture 
Bone marrow  cells were inoculated onto PA6 cell layers at 5  x  104 
cells/60-mm dish and cocultured in liquid medium for 2 d. Then adher- 
ent cell layers were covered with a collagen gel, and cocultures were con- 
tinued by changing of the medium, added onto the gel up to day 42. 
* Twice a week, location of newly emerging macroscopic  colonies within 
two dishes was recorded, and their persistence was inspected. 
Figure 9.  Time course of the hemopoiesis  supported by the cells of sub- 
clones of PA6 clone. Cell layers of PA6 clone (O), subclone 2 (A), sub- 
done 12 (V), subclone 14 (I), a mixture of PA6 clone and subdone 2 (A), 
a mixture of PA6 clone and subclone 12 (~7)), or a mixture of PA6 clone 
and subdone 14 ([]) were established  in 35-mm dishes. Bone marrow cells 
were inoculated onto these cell layers and cocuhured,  and nonadherent 
cells were counted as described in the legend to Fig. 3. 
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until day 42. These results demonstrate that, in the untreated 
cocultures, most of the macroscopic colonies are formed by 
hemopoietic stem cells having limited proliferative capacity. 
Fig. 8 illustrates the appearance of individual macroscopic 
colonies and their persistence  in the cocultures treated with 
10 #g/ml ACK2 for the initial 4 d. Bone marrow cells were 
inoculated at 2  x  10  s cells/dish. A total of 37 macroscopic 
colonies were formed in three such dishes during 6 wk of 
observation,  showing that as many as  "~95%  of the cells 
capable of forming macroscopic colonies in the present colony 
assay system were killed by the ACK2 treatment. New mac- 
roscopic colonies emerged until as late as 39 d after inocula- 
tion.  13 colonies (35%) were observed at more than three 
observation times, while 17 colonies (46%) were detected 
on one occasion only. Nine colonies (24%) persisted until 
end of the observation period. These colonies reached a mac- 
roscopic size on or later than day 18. These observations dearly 
demonstrate that hemopoietic stem cells having higher prolifer- 
ative capacity preferentially survive the ACK2 treatment. 
Properties of Subclones of PA6 Cell Line That Are Incapable 
of  Supporting Long-Term Hemopoiesis.  Above observations of 
the fate of individual colonies indicate that the apparently 
constant level of hemopoietic cell production in our cocul- 
ture system is maintained by successive bursts of the prolifer- 
ation and differentiation of hemopoietic stem cells having 
varying proliferative properties.  Hemopoietic cell production 
by the stem cells having higher proliferative capacity tended 
to occur later.  To further explore the mechanism through 
which PA6 cells support the proliferation of the hemopoietic 
stem cells having extensive proliferative capacity, we isolated 
subclones incapable of supporting long-term hemopoiesis from 
PA6  done. 
Table  3.  Inability of rmc-kit Ligand to Cure the Defect of 
Subclones of PA6 Clone 
Cell layers 
No.  of nonadherent cells/dish* 
rmc-kit ligand  On day 14  On day 21 
PA6 clone  -  2.0  x  1@  1.5  x  106 
+  2.5  x  106  1.8  x  106 
Subclone 2  -  4.2  x  10  s  3.2  x  104 
+  6.0  x  10  s  1.7  x  104 
Subdone  12  -  6.6  x  10  s  1.7  x  104 
+  8.7  x  10  s  4.3  x  104 
Subclone 14  -  9.0  x  10  s  7.0  x  10  s 
+  1.6  x  10  ~  1.4  x  10  s 
Bone marrow cells were inoculated  at 3  x  10  s cells/35-mm  dish onto 
the cell layers of PA6 clone or one of its subclones and cocultured  in 
the absence or presence of 50 ng/ml partially purified rmc-kit ligand. 
* Nonadherent  cells  were harvested  and counted  as described  in the legend 
to Fig. 3. 
When bone marrow ceils were cocultured with the cells 
of subdone 2, 12, or 14, active nonadherent cell production 
was sustained for only 2 wk, and then hemopoiesis declined 
rapidly, while the low level of hemopoiesis continued for a 
significantly prolonged period in the cocultures with sub- 
clone 14 cells (Fig.  9, Table 3). These observations demon- 
strate that these subdones have lost the capacity to support 
the proliferation of the hemopoietic stem cells having exten- 
sive proliferative capacity. All of these subdones retained the 
capacity to differentiate into adipocytes (26) at low frequency 
and to support megakaryopoiesis (27) as actively as parental 
PA6 clone (data not shown). Subclones 2 and 12 also retained 
the capacity to support osteoclast differentiation (34) as ac- 
tively as PA6 clone, but subclone 14 had completely lost such 
capacity (data not shown). These observations suggest that 
these subclones  of PA6 clone have lost the expression of a 
small number of genes. 
Then, we mixed equal numbers of parental PA6 cells and 
each of the subclone cells and established  cell layers. When 
bone marrow cells were inoculated onto these mixed cell layers 
and cocultured, the level of nonadherent cell production was 
intermediate between that in the cocultures with PA6 cells 
and that with subclone cells (Fig.  9).  Hemopoiesis within 
the cocultures with the mixture of PA6 cells and subclone 
cells declined slowly after the initial 2 wk of active hemopoi- 
esis but continued for a significantly longer period than that 
supported by any of subclone cells. Therefore, inability of 
the subclone cells to support long-term hemopoiesis is un- 
likely to be due to their production of inhibitory molecule(s). 
Although the reason why the mixed cells were not as active 
as PA6 cells alone in the support of hemopoiesis is not clear, 
hemopoietic stem cells may have difficulty  in maintaining their 
proliferative capacity, if the stem cells do not have the ability 
to selectively  contact parental PA6 clone cells. 
To determine whether the inability of the subclone cells 
to support the proliferation of primitive hemopoietic stem 
cells is due to their lack of gene expression of the c-kit ligand, 
we prepared mKNA from PA6 cells, each of subclone cells, 
and ST2 cells and amplified transcripts of c-kit ligand gene 
and B-actin gene by the RT-PCR method. As shown in Fig. 
10, no significant difference in the level of the expression  of 
Figure 10.  Electrophoretic  analysis of the products of KT-PCR am- 
plification  using  oligonudeotide  primers of  c-kit  ligand  and B-actin. Total 
RNA isolated  from the indicated  cells was used as template  for cDNA 
synthesis  and subsequent  RT-PCK  amplification  in combination  with two 
pairs of oligonucleotide  primers: rat c-kit  ligand and mouse  B-actin. The 
products were  separated  by electrophoresis,  and bands of c-kit ligand  (272 
bp) and/3-actin  (430 bp) were visualized  by ethidium  bromide staining. 
Lane 1, molecular  weight markers; lane  2, ST2 cells; lane  3, PA6 cells; 
lane 4, subclone  2 cells;  lane  5, subdone  12 cells; lane  6, subdone  14 cells. 
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of done PA6 or of any of its subdones. ST2 cells, capable 
of supporting the proliferation of bemopoietic stem cells and 
their differentiation into both myeloid and B lymphoid cells 
(29, 30),  also expressed c-kit ligand mKNA. Furthermore, 
we exogenously supplied 50 ng/ml partially purified rmc-kit 
ligand to the cocultures of bone marrow cdls and the cells 
of PA6 done or one of the subdones. As shown in Table 
3,  the rmc-kit ligand slightly enhanced the production of 
nonadherent cells during first 2 wk of coculture but did not 
cure the defect of the subclone cells in the ability to support 
long-term hemopoiesis. These results seem to exclude the pos- 
sibility that the ability of PA6 cells to support the prolifera- 
tion of the hemopoietic stem cells having extensive prolifera- 
tive capacity is not solely borne by their expression of c-kit 
ligand. 
Discussion 
In  the  present  study,  our  first  question  was  whether 
hemopoietic stem cells having extensive proliferative capacity 
can proliferate  within cocultures of bone marrow ceils and 
PA6  calls. We  first  cocultured varying numbers of bone 
marrow cells with the preadipocytes.  Frequency of the stem 
cells capable of sustaining hemopoiesis within the cocultures 
for 6 wk was estimated to be 1/5.3  x  104 bone marrow 
cells by limiting dilution analysis. We next examined the pres- 
ence of the primitive hemopoietic stem calls within  the 
hemopoiesis-positive dishes into which bone marrow cells 
had been inoculated at 2.5  x  104 cells/dish.  Hemopoietic 
cells harvested from each of seven such dishes were injected 
into each of seven WBB6F:-W/W ~ mice. At 24 wk after the 
injection, erythropoiesis was reconstituted completely in two 
recipient mice and partially in one mouse by the injected stem 
cells. These results demonstrate that PA6 cells can support 
the proliferation of the hemopoietic stem ceils having exten- 
sive proliferative capacity. It is unlikely that dormant primi- 
tive stem cells may have accidentally strayed into the hemo- 
poiesis-positive  dishes,  since frequency of more primitive 
hemopoietic stem cells must be lower than that of more 
differentiated ones. 
Although, judging from the statistical point of view, the 
sample number in our present experiment is not sufficient, 
the frequency of the stem cells capable of sustaining hemopoi- 
esis throughout our present experiment, i.e., 6 wk in vitro 
and 24 wk in vivo, can be roughly estimated. Since, in the 
group of dishes into which bone marrow cells had been in- 
oculated at  2.5  x  104 cells/dish, hemopoietic stem cells 
having long-term reconstituting capacity were detected in 
3 of 19 dishes (16%), the mean number of such stem cells/dish 
is estimated to be 0.17 (35). Therefore, the concentration of 
the primitive hemopoietic stem cells in the starting bone 
marrow  cell population is  calculated to be 6.8/106  ceils. 
Nakano et al. (7) injected varying numbers of bone marrow 
cells freshly isolated  from C57BL/6 mice into WBB6F1- 
W/W ~ mice and estimated by limiting dilution analysis the 
concentration of the primitive hemopoietic stem cells to be 
9/106 bone marrow cells. By comparison of these estima- 
tions, ,u75% of the primitive hemopoietic stem cells are sup- 
posed to have sustained their proliferative capacity during 6 
wk of the coculture with PA6 cells, showing that PA6 cells 
can provide a fairly suitable microenvironment  for the prolifer- 
ation of primitive hemopoietic stem ceils. 
To explore the proliferation of individual hemopoietic stem 
cells in our coculture system, we developed a colony assay 
system of the stem ceils. Bone marrow cells and PA6 cells 
were initially cocultured in liquid medium for 2-4 d to allow 
the stem cells to enter into the PA6 cell layers (27, 28). Then 
the adherent cell layers were covered with a collagen gd to 
restrict the movement of hemopoietic ceUs. Clonality of the 
colonies may be obscured during the initial period of liquid 
culture. However, hemopoietic progenitor cells capable of 
forming multilineage colonies in methylcdkilose  cultures are 
strongly suggested to be in Go state  for a variable period 
after inoculation, and, when triggered into cell cycle, they 
proliferate at relatively constant doubling rates (36). Nakano 
et al. (7) reported that hemopoietic stem cells capable of recon- 
stituting in vivo hemopoiesis are not in S phase. It appears 
to take only 4-5 d for the colonies in our colony assay system 
to reach macroscopic size, since population doubling time 
of the cells within the colonies was 7-8 h (H. Kodama, un- 
published  observations).  Accordingly,  many  of the  cells 
forming macroscopic colonies are considered to have stayed 
in Go state during the liquid culture period. Even if some 
of the colony-forming cells entered into the cell cycle during 
the liquid culture period, their movement would be restricted, 
since they proliferate exclusively  within the adherent cell layers 
in close contact with PA6 cells (27,  28). 
The time course of  colony formation in our coculture system 
seems to be equivalent to that of spleen colony formation, 
since the population doubling time of the cells within the 
colonies was similar to the shortest cell-cyde time of mam- 
malian cells (37).  Therefore, macroscopic colonies detected 
at around the second week ofcoculture probably correspond 
to the spleen colonies. The number of the in vitro colonies 
decreased to about half at every twice-a-week counting from 
day 11 to 32. Consequently, colonies detected on day 42 were 
as few as •2.5%  of those detected on day 11, indicating that 
most of the colonies are formed by the hemopoietic stem 
cells having limited proliferative  capacity. 
The frequency of the hemopoietic stem ceils estimated by 
the number of macroscopic colonies on day 42 of coculture 
was about half of that estimated by limiting dilution anal- 
ysis. In the colony assay system, hemopoietic cells were re- 
stricted to grow within a small area, while the cells could 
disperse over the entire surface of 35-mm dishes in the lim- 
iting dilution assay. Competition among hemopoietic ceils 
for contact with PA6 cells may occur within the colonies. 
If this is the case, it may be difficult for stem cells to maintain 
their proliferative  capacity in the colony assay system. De- 
spite this drawback, our present colony assay system enabled 
us to dissect the heterogeneous population of hemopoietic 
stem cells having varying proliferative  capacities. 
We found by sequential observations of individual macro- 
scopic colonies that new macroscopic colonies continuously 
358  In Vitro Growth of Hemopoietic Stem Cells Supported by Stromal Cells emerged until  as  late  as  39  d after  inoculation.  Such an  asyn- 
chrony in  the  development of  colonies  has  been already  ob- 
served  in  the  colony formation  in  both spleens  (38,  39) and 
methylcenulose  cultures  (36).  After  varying  periods  of sus- 
tained  hemopoiesis,  most of  the  colonies  suddenly  disappeared, 
similarly  as  observed  in  the  spleen  colonies  (38,  39).  Conse- 
quently,  only  8% of  the  macroscopic  colonies  were detected 
at  more than three  twice-a-week  observation  times,  i.e.,  for 
>8 d; and only one out of  a total  of 141 colonies  persisted 
until  the  end  of  the  42  d of  our  observation  period.  Although 
the colonies  emerging later  tended to persist  for a longer 
period,  the  fate  of  individual  colonies  was  unpredictable.  Both 
the asynchrony in the development of  colonies  and the un- 
predictability  of  their  fate  seem to  indicate  the  stochastic  na- 
ture  of the responses  of the hemopoietic stem cells  to en- 
vironmental stimuli  (36,  40, 41).  Nevertheless,  no colonies 
having  reached  macroscopic  size  before  day 18  persisted  until 
day 42, suggesting  that  hemopoietic stem cells  capable  of 
reconstituting  in  vivo  hemopoiesis  may not  form  macroscopic 
colonies  in spleens  at least  within 14 d after  injection. 
Our second question  was whether PA6 cells  support  the 
proliferation  of  primitive  hemopoietic stem ceils  through a 
mechanism involving  the c-kit  receptor  and its  ligand.  For 
this  purpose,  we first  utilized  a mAb, ACK2, recognizing 
an  extracellular  domain of  the  c-kit  molecule,  since  this  anti- 
body has been strongly suggested to antagonistically block 
the function of the c-kit receptor (22, 23). Addition of the 
antibody to the cocultures of bone marrow cells and PA6 
cells resulted in the severe reduction in the hemopoietic cell 
production. Only '~6% of day 12 CFU-S survived after 4 d 
of coculture in the presence  of ACK2,  while the CFU-S 
number in the untreated cocultures increased about three- 
fold during the same period. These results are consistent with 
the findings that injection of ACK2 into mice results in a 
simultaneous disappearance of CFU-S and hemopoietic pro- 
genitor cells assayable in vitro by using various hemopoietic 
factors (23), and that colony formation of CFU-S is inhibited 
by the injection of the antibody into recipient mice (24). 
However,  when  the  cocultures  were  continued  with 
antibody-free medium after 4 or 14 d of the ACK2 treat- 
ment, hemopoiesis dramatically recovered to the level of that 
in the untreated cocultures. Our colony assay system enabled 
us to clarify the difference of the hemopoietic stem cells sur- 
viving the ACK2 treatment in their proliferative  properties 
from those of the majority of the stem cells. Only '~5% of 
the cells forming macroscopic colonies in the cocultures of 
bone marrow cells and PA6 cells survived the 4 d of ACK2 
treatment. On day 11 of coculture, the number of macro- 
scopic colonies detected in the ACK2-treated cocultures was 
"~2.5% of that in the untreated cocultures. However, at later 
than day 28, colony number in the ACK2-treated cocultures 
was comparable to that in the untreated cocultures. The fre- 
quency of the macroscopic colonies persisting for >8 d in 
the ACK2-treated cocultures was fourfold higher than that 
in the untreated cocultures. Furthermore, as many as 24% 
of the colonies persisted until day 42 in the ACK2-treated 
cocultures,  while only I of  141 colonies  persisted  in  the  un- 
treated  cocultures.  These results  clearly  demonstrate that 
hemopoietic stem cells  having higher  proliferative  capacity 
preferentially  survive  the ACK2 treatment. 
The above finding  that  primitive  hemopoietic stem ceils 
are resistant  to ACK2 treatment  does  not necessarily  mean 
that  the c-kit  molecule is  not expressed  on such stern  cells, 
since  the  ACK2 antibody  has  been strongly  suggested  to  be 
cytostatic  rather  than cytotoxic  for the cells  expressing  its 
antigen (22,  23).  In fact,  Okada et al. (24)  and Ikuta  and 
Weissman (25) found that only the cells  of the lineage 
marker-negative  and c-kit-positive  fraction  of  bone marrow 
cells  can  reconstitute  the  lymphohemopoietic system  of  lethally 
irradiated  mice. Although CFU-S exist  exclusively  in the 
c-kit-positive  fraction  (24,  25),  a small  but significant  frac- 
tion  of  day 13 CFU-S is  resistant  to  ACK2 (23),  and colony 
formation of day 12 CFU-S is less  effectively  inhibited  by 
the injection  of  ACK2 into  recipient  mice than that  of  day 
8 CFU-S (24).  Therefore,  it  is  likely  that  the c-kit  molecule 
is  expressed  on all  the hemopoietic stem cells  but that  the 
stem cells  at  the  earlier  stage  are  less  dependent on the  signal 
transduction  through the  c-kit  receptor.  Recently,  Ikuta  and 
Weissman (25)  reported  that  SI/SI  homozygote fetuses,  which 
lack  genes  to encode functional  c-kit  ligand  (20,  21),  have 
30-40% of the number of  hemopoietic stem ceils  in their 
liver  when compared with normal littermates,  and that  the 
absolute  number of  hemopoietic stem cells  increases  during 
fetal  development in the SI/SI  mice. 
Next, we isolated  three  subdones incapable  of  supporting 
long-term hemopoiesis from the PA6 clone.  When bone 
marrow cells  were cocultured  with the calls  of these  sub- 
clones,  active  hemopoiesis continued for only 2 wk, indi- 
cating  that  the subclone  ceils  have  lost  the capacity  to sup- 
port the proliferation  of primitive  hemopoietic stem ceils. 
These three  defective  subclones  were found by testing  only 
17  subclones  isolated  from  highly  passaged  PA6 clone.  Mixed 
cell  layers  comprising the  PA6 clone  and  any  of  the  defective 
subclones  supported hemopoiesis for a significantly  longer 
period  than 2 wk. Therefore,  inability  of  the subclone  cells 
to  support  long-term  hemopoiesis  is  unlikely  to  have  resulted 
from either mutation in some gene or their production of 
some inhibitory molecule(s). 
Production of functional c-kit ligand by the subclone cells 
seems to be apparent, since active hemopoiesis in the cocul- 
tures of bone marrow cells and the subclone cells continued 
significantly longer than that in the ACK2-treated cocultures 
of bone marrow cells and PA6 cells. In fact, we failed to de- 
tect any significant  difference in the level of expression of 
mKNA for c-kit ligand between the cells of PA6 clone and 
any of its subclones. The defect of the subclone cells was not 
cured by the exogenous supply of rmc-kit ligand. These results 
suggest that merely expressing c-kit ligand is not enough for 
PA6 cells to support the proliferation of primitive hemopoietic 
stem cells. 
In conclusion, our present study has demonstrated that 
a combination of our in vitro colony assay system and ACK2 
359  Kodama et  al. mAb provides a powerful tool for the analysis of the prolifer- 
ative properties of primitive hemopoietic stem cells. The results 
obtained by use of both the antagonistic ACK2 mAb  and 
the defective subclones of PA6 done consistently suggest that 
the mechanism involving c-kit receptor and its ligand does 
not play a major role in the survival and proliferation of primi- 
tive hemopoietic stem cells. 
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